Concepedia

Carlos Perdomo

CP

45

Publications

4.5K

Citations

32

H-Index

1984

Active since

Affiliations

Eisai (United States)(Current)

Eisai (Japan)

Eisai (United Kingdom)

Pfizer (United States)

The University of Texas Southwestern Medical Center

Carlos Perdomo is an author at Eisai (United States) specializing in medicine, neurology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

1984–2022

45

Publications

45

A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

Richard C. Mohs, Rachelle S. Doody, John C. Morris et al. · Neurology · 2001 · 505 citations

Efficacy and Tolerability of Donepezil in Vascular Dementia

Sandra E. Black, Gustavo C. Román, David Geldmacher et al. · Stroke · 2003 · 381 citations · Full text

A Randomized, Double‐Blind, Placebo‐Controlled Study of the Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease in the Nursing Home Setting

Pierre N. Tariot, Jeffrey L. Cummings, Ira R. Katz et al. · Journal of the American Geriatrics Society · 2001 · 362 citations

Rufinamide for generalized seizures associated with Lennox–Gastaut syndrome

Tracy A. Glauser, Gerhard Kluger, Rajesh Sachdeo et al. · Neurology · 2008 · 347 citations

Randomized, Placebo-Controlled Trial of the Effects of Donepezil on Neuronal Markers and Hippocampal Volumes in Alzheimer’s Disease

Kousik Krishnan, H. Cecil Charles, P. Murali Doraiswamy et al. · American Journal of Psychiatry · 2003 · 286 citations

Rows per page

1–5 of 45